BioMarin Pharmaceutical Inc. - BMRN (NASDAQ-GS)

89.12
0.66 (-0.74%)
Quotes delayed 15 mins. Currently January 19, 2018 4:36:38 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
BioMarin develops and markets therapeutics for genetic metabolic disorders

Key Financials

Day Range:88.98 - 90.04
52 Week Range:80.10 - 100.51
Open:89.55
Shares:175.62M
Market Cap:15.65B
EPS:-0.88
P/E Ratio:--
Div Yield:--
Performance
Previous close
No Chart Available
Purchase BMRN in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of BMRN not only as a single stock, but also as part of a motif.
Professional Motifs with BMRN
Biotech Breakthroughs
Biotech Breakthroughs 14.9% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with BMRN
What Others Think About BMRN
Gabriel Wilson
As Biomarin Pharmaceutical $BMRN Market Value Declined, Nomura Asset Management Company LTD Has Lifted Hold...
Steven Dickman
RT @arleneweintraub : Gene therapies for blood disorders could have a breakout year in 2018, predicts @amandamicklus @Pharma_Intell https://…
2
Boaty McBoatface
RT @arleneweintraub : Gene therapies for blood disorders could have a breakout year in 2018, predicts @amandamicklus @Pharma_Intell https://…
2
Arlene Weintraub
Gene therapies for blood disorders could have a breakout year in 2018, predicts @amandamicklus @Pharma_Intelltwitter.com/i/web/status/9…
2 5
Rik
RT @tgtxdough : CS new analyst Martin Auster has joined Credit Suisse new biotech coverage $ALXN $BMRN $BIVV $MYOK $ESPR $RARE $ONCE $EDGE…
12
US Banking News
BioMarin Pharmaceutical’s $BMRN “Buy” Rating Reaffirmed at Piper Jaffray Companies americanbankingnews.com/?p=5633408 #stocks
Dispatch Tribunal
BioMarin Pharmaceutical’s $BMRN “Buy” Rating Reaffirmed at Piper Jaffray Companies dispatchtribunal.com/?p=886366
StockNews.com
$BMRN Piper Jaffray reiterates Buy rating, $114 PT stocknews.com/news/bmrn-pipe…
Related Companies Within The Biotechnology Sector
TIG
TiGenix - 41.94
TIG
Amgen Inc. - 189.28
AMGN
GILD
CELG
Biogen Inc. - 342.41
BIIB